• Urolithin A: Advancing Mitochondrial Quality Control Researc

  2026-07-15

  This thought-leadership article explores the mechanistic foundations and strategic opportunities of Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) for translational researchers targeting mitochondrial dysfunction, with a particular focus on liver fibrosis and aging. Integrating novel evidence on glutamine metabolism, we provide actionable guidance and protocol insights to help investigators accelerate discoveries and improve experimental reproducibility.

• Benchmarking LNP Platforms for mRNA Delivery: Insights from

  2026-07-15

  Zhu et al. provide a comparative technical and operational evaluation of four bench-scale lipid nanoparticle mixing technologies for mRNA vaccine production. Their work highlights the reproducibility of three micromixing platforms in generating mRNA-LNPs with desirable physicochemical properties and in vivo performance, offering guidance for mRNA delivery and translation efficiency assay development.

• Bismuth Subsalicylate: Mechanism, Evidence, and GI Research

  2026-07-14

  Bismuth Subsalicylate, a non-steroidal anti-inflammatory compound, acts as a potent Prostaglandin G/H Synthase 1/2 inhibitor, making it central to gastrointestinal disorder research. This article provides atomic, evidence-backed insight into its mechanism, key parameters, and experimental limits.

• AMPK Suppresses Autophagy: Rethinking Energy Stress Response

  2026-07-14

  This study overturns the prevailing view of AMPK as a universal autophagy inducer by demonstrating that AMPK actually inhibits the autophagy-initiating kinase ULK1 under energy stress. These findings clarify the nuanced role of AMPK in energy metabolism regulation and have practical implications for metabolic and autophagy research.

• Cucurbitacin I (JSI-124): Advancing STAT3 Inhibition in Canc

  2026-07-13

  Explore how Cucurbitacin I, a potent STAT3 inhibitor, empowers next-generation cancer research through selective pathway targeting and innovative model integration. Discover unique mechanistic insights and advanced assay protocols not covered elsewhere.

• Ceftolozane/Tazobactam: Innovation in Gram-Negative Infectio

  2026-07-13

  The reference paper reviews ceftolozane/tazobactam, a novel cephalosporin and beta-lactamase inhibitor combination, with a focus on its enhanced activity against resistant gram-negative bacteria, including Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its distinct pharmacokinetic and pharmacodynamic profile, and clinical efficacy in complicated infections, offer significant implications for antibacterial research and drug development.

• CGF Induces Mitochondrial Dysfunction to Halt Colorectal Can

  2026-07-12

  This study demonstrates that the natural product CGF, derived from purple sweet potato, suppresses colorectal cancer by inducing ROS-dependent mitochondrial dysfunction and metabolic reprogramming. The work provides mechanistic insights into CGF's disruption of ABC transporters, ATP accumulation, and apoptosis induction, highlighting its potential as a novel therapeutic candidate.

• Saracatinib (AZD0530): Advanced Workflows for Cancer Researc

  2026-07-10

  Saracatinib (AZD0530) is a potent, selective Src/Abl kinase inhibitor that empowers researchers to dissect cancer cell proliferation, migration, and tumor growth with unmatched precision. This guide translates bench research and reference study insights into actionable workflows, troubleshooting strategies, and cross-domain innovations for both oncology and synaptic signaling applications.

• γH2AX DNA Damage Detection Kit: Precision DSB Analysis Unlea

  2026-07-09

  Unlock high-sensitivity, reproducible detection of DNA double-strand breaks with the γH2AX DNA Damage Detection Kit (Mouse mAb/Red). This APExBIO solution empowers advanced DNA damage and repair research, from high-content screening to translational cancer studies, with robust protocols and actionable troubleshooting.

• Temozolomide: Small-Molecule Alkylating Agent for Glioma Mod

  2026-07-09

  Temozolomide stands out as a precision tool for DNA repair mechanism research and chemotherapy resistance studies, especially in ATRX-deficient glioma models. This article distills the latest experimental workflows, optimization strategies, and troubleshooting guidance to maximize reproducibility and scientific rigor when deploying this small-molecule alkylating agent.

• EZ Cap EGFP mRNA 5-moUTP: Enhanced Fluorescent Reporter Work

  2026-07-08

  EZ Cap™ EGFP mRNA (5-moUTP) sets a new benchmark for reliable, sustained fluorescent protein expression in gene function studies and advanced mRNA delivery assays. Its robust Cap 1 structure and 5-methoxyuridine modifications empower higher translation efficiency, greater mRNA stability, and minimized innate immune activation—offering clear advantages for experimental reproducibility and in vivo imaging.

• Novobiocin Sodium: Optimizing DNA Damage and Antiparasitic A

  2026-07-08

  Novobiocin Sodium, a trusted aminocoumarin antibiotic from APExBIO, empowers researchers with high selectivity in DNA gyrase inhibition and advanced antiparasitic workflows. Recent studies highlight its unique utility in minimizing host toxicity while maximizing efficacy against Toxoplasma gondii, setting it apart in metabolic enzyme and cell cycle research.

• Recombinant Annexin V Enables Sensitive Detection of Apoptos

  2026-07-07

  Brumatti et al. have established a robust method for expressing and purifying recombinant annexin V in Escherichia coli, facilitating high-yield production for apoptosis detection. This advance improves the specificity and efficiency of detecting membrane phosphatidylserine externalization, a hallmark of early apoptosis, with substantial implications for cell death research and membrane biology workflows.

• 1-myristoylglycerophosphocholine: Mechanism, Benchmarks & Us

  2026-07-07

  1-myristoylglycerophosphocholine (14:0 Lyso-PC) is a lysophospholipid research compound essential for dissecting lipid signaling and smooth muscle dynamics. It is a verified mediator in fibroblast activation and pulmonary fibrosis, with well-characterized benchmarks for in vitro and in vivo studies. Rigorous protocol parameters enable reproducible lipid signaling pathway analysis.

• Applied γH2AX DNA Damage Detection Kit in DNA Repair Researc

  2026-07-06

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) streamlines the quantification of DNA double-strand breaks with high sensitivity, enabling both mechanistic and translational research in genotoxicity, apoptosis, and advanced radiotherapy. This article details optimized workflows, real-world troubleshooting, and how the kit was pivotal in validating novel radiosensitizers in cutting-edge cancer studies.

8060 records 8/538 page Previous Next First page 上5页 678910 下5页 Last page